Xwpharma

Developer of drugs for treating neurological disorders like epilepsy, Parkinson's & others

placeSan Francisco, California, United States calendar_todayFounded 2014 groups15 employees language xwpharma.com

Innovation

17 patent families (15 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 2,932 times.

YearFilings
20171
20202
20219
202214
202313
202412
202510
20265

Investor mix

14 investors on record; lead investors include Kleiner Perkins, WI Harper Group, Element Capital, Panacea Venture.

Investor typeCountShare
Venture capital857%
Private equity17%
Other / undisclosed536%
Coming soon